An open-label phase II study evaluating the safety and efficacy of ramucirumab combined with mFOLFOX-6 as first-line therapy for metastatic colorectal cancer
- Garcia-Carbonero, R.
- Rivera, F.
- Maurel, J.
- Ayoub, J.-P.M.
- Moore, M.J.
- Cervantes, A.
- Asmis, T.R.
- Schwartz, J.D.
- Nasroulah, F.
- Ballal, S.
- Tabernero, J.
ISSN: 1549-490X, 1083-7159
Year of publication: 2014
Volume: 19
Issue: 4
Pages: 350-351
Type: Article